Tag Archives: Acorda
Biotech Head: Kyle Bass Not the Problem
New York (HedgeCo.net) – Kyle Bass probably isn’t on the invitation lists of very many biotech and pharma companies’ holiday lists, but the head of one biotech firm recently stated that Bass isn’t the problem. In an interview on CNBC’s […]
